Observational, retrospective study, conducted in diabetic patients aimed to evaluate the effects on the glyco-metabolic control and on cardiovascular events of different DPP-4 inhibitors. Patients will be stratified in patients taking different DPP-4 in addition to sulfonylureas, biguanides, thiazolidinediones, insulin, compared to those in therapy with other hypoglycemic classes, such as sulphonylureas, biguanides, thiazolidinediones, insulin, alone or in combination, in primary and secondary prevention.
Study Type
OBSERVATIONAL
Enrollment
2,234
Patients will be retrospectively evaluated after the addition of a DPP-4 inhibitor to previously taken anti-diabetic therapy
IRCCS Policlinico San Matteo Foundation
Pavia, Lombardy, Italy
Glycated hemoglobin
Percentage
Time frame: 8 years
Fasting plasma glucose
mg/dl
Time frame: 8 years
Post-prandial plasma glucose
mg/dl
Time frame: 8 years
Angina pectoris
Percentage
Time frame: 8 years
Extrasystoles
Percentage
Time frame: 8 years
Atrial fibrillation
Percentage
Time frame: 8 years
Fatal myocardial infarction
Percentage
Time frame: 8 years
Non-fatal myocardial infarction
Percentage
Time frame: 8 years
Heart failure
Percentage
Time frame: 8 years
Cardiovascular death
Percentage
Time frame: 8 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.